Lenz Therapeutics, Inc. — Form D/A
Lenz Therapeutics, Inc. of DEL MAR, CA, a company, filed a Form D amendment with the SEC on 2022-11-22. The offering totals $49.0M, of which $49.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-11-22
- Form: D/A
- Accession: 0001678518-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $49.0M
- Amount sold: $49.0M
- Investors: 45
- Date of first sale: 2020-10-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-380075
Issuer
- Name: Lenz Therapeutics, Inc.
- CIK: 0001678518
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 445 MARINE VIEW AVE., SUITE #320, DEL MAR, CA, 92014
- Phone: 619-890-5125
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Fred Guerard | Director | Del Mar, CA |
| Zach Scheiner | Director | Boston, MA |
| CHRIS DIMITROPOULOS | Director | SAN DIEGO, CA |
| Clare Ozawa | Director | South San Francisco, CA |
| Evert Schimmelpennink | Director | Bryan, TX |
| Evert Schimmelpennink | Executive Officer | Bryan, TX |
| Mark Lester | Executive Officer | Tucson, AZ |
| James McCollum | Director | Del Mar, CA |
| James McCollum | Executive Officer | Del Mar, CA |
| Stefan Larson | Director | Del Mar, CA |
| Frederic Guerard | Director | Dedham, MA |
| Mark W Lester | Director | Wellesley, MA |
| Mark W Lester | Executive Officer | Wellesley, MA |
| Gerald W Horn | Director | Deerfield, IL |
| Gerald W Horn | Executive Officer | Deerfield, IL |
| James W McCollum | Director | Coronado, CA |
| James W McCollum | Executive Officer | Coronado, CA |
| GERALD HORN | Executive Officer | CORONADO, CA |
Other filings by this issuer (4)
More